ARTICLE | Company News
NBE-Therapeutics, Sotio deal
October 24, 2016 7:00 AM UTC
Sotio and NBE partnered to discover and develop next-generation antibody-drug conjugates (ADCs) against undisclosed targets to treat cancer. The collaboration will use NBE’s Transpo-mAb antibody platf...